study comparing Proscar (finasteride) with Hytrin (terazosin) for BPH is causing quite a stir

The recently published study comparing Proscar (finasteride) with Hytrin (terazosin) for BPH is causing quite a stir.

News reports are saying Proscar is "virtually worthless"... prompting lots of calls from concerned patients.

This is the same study we alerted you to last year...it's just now being published in the New England Journal of Medicine.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote